Description
A methylhypoxanthine that is hypoxanthine with the methyl group at position 1.
Chemical properties
| Chemical formula | Net charge | Average mass |
|---|---|---|
| C6H6N4O | 0 | 150.141 |
Recommended notation
| Name | 1-methylhypoxanthine |
|---|---|
| Abbreviation | 1mHyp |
Nomenclature
| IUPAC | SMILES | InChI | InChIKey | Synonyms |
|---|---|---|---|---|
| 1-methyl-1,7-dihydro-6H-purin-6-one | Cn1cnc2nc[nH]c2c1=O | InChI=1S/C6H6N4O/c1-10-3-9-5-4(6(10)11)7-2-8-5/h2-3H,1H3,(H,7,8) | KIQMCGMHGVXDFW-UHFFFAOYSA-N |
|
Citations
- Buhl, L, et al. 1985. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice. Cancer Research. 45(3).
- Dutta, SP, et al. 1987. Metabolism of 1-methyladenosine. Biochemical Medicine and Metabolic Biology. 38(1).
- Hanski, C, et al. 1980. Increased concentration of 7-methylguanine and 1-methylhypoxanthine in urine of rats bearing Yoshida tumour. Cancer Letters. 9(4).
- Law, KP, et al. 2017. Tryptophan and purine metabolites are consistently upregulated in the urinary metabolome of patients diagnosed with gestational diabetes mellitus throughout pregnancy: A longitudinal metabolomics study of Chinese pregnant women part 2. Clinica Chimica Acta; International Journal of Clinical Chemistry. 468.
- Levy, M, et al. 1999. The prebiotic synthesis of modified purines and their potential role in the RNA world. Journal of Molecular Evolution. 48(6).